On-Demand Digital Pathology - affordable - unique - research and clinical users

 

 

Nikon and OptraSCAN announce strategic partnership to accelerate adoption of Affordable Digital Pathology in North America

Customers to benefit from cloud-enabled whole slide scanners and AI & ML-based analytics at affordable cost

MELVILLE, N.Y. and SAN JOSE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Nikon Instruments Inc.., innovator of advanced optical instruments and OptraSCAN®, the leading on-demand digital pathology solution provider today announced a strategic partnership to accelerate adoption of affordable digital pathology in the North American region. As part of this collaboration, Nikon will distribute OptraSCAN’s Brightfield and Fluorescence whole slide imaging scanners with capacity from 1 to 120 slides, as well as integrated TelePathology and artificial intelligence (AI) and Machine Learning (ML)- based analytics solutions.

OptraSCAN® On-Demand desktop scanning systems are cloud-enabled and provide the ultimate flexibility for storing, archiving and managing digital images and metadata. Convenient for Brightfield, Fluorescence, and Multi-modality whole slide imaging, these small footprint, low and high throughput scanners are lightweight that can easily fit into small workspaces. OptraSCAN’s end-to-end solutions include TELEPath - a comprehensive telepathology solution, AI & ML-based image analysis solutions for immunotherapy, prostate cancer and immunohistochemistry applications.

“The Nikon Instruments team is excited about our new partnership with OptraSCAN,” said Steve Ross, Ph.D., General Manager, Products and Marketing, Nikon Instruments Inc. “This partnership will enable us to deliver innovative solutions that will help digital pathology become more efficient and affordable.”

“By partnering with Nikon Instruments, OptraSCAN aims to take digital pathology to the next level of adoption across the continent,” said Abhi Gholap, Founder & CEO, OptraSCAN. “Combining our automated whole slide scanners and AI enabled analytics together with Nikon’s strong market presence, this alliance will serve compelling propositions to our customers for quickly implementing our most advanced and affordable digital pathology solutions.”

About Nikon Instruments Inc.

Nikon Instruments Inc. is a world leader in the development and manufacturing of optical and digital imaging technology for biomedical applications. Cutting-edge instruments include microscopes, digital imaging products and software. Nikon Instruments is one of the microscopy and digital imaging arms of Nikon Inc., the world leader in digital imaging, precision optics and photo imaging technology. For more information, visit www.nikoninstruments.com. Product-related inquiries may be directed to Nikon Instruments at 800-52-NIKON.

About OptraSCAN, Inc.

OptraSCAN® (www.optrascan.com) are pioneers in the On-Demand Digital Pathology® System, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the barriers to “Go Digital” no matter the size of the pathology lab, the lab's throughput or global location.

OptraSCAN’s end-to-end digital pathology solution provides effective acquisition of whole slide images, viewing, storing, real time sharing, reporting and AI & ML based Image analysis solutions via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter.

Contacts:

Media Inquiries: (For Nikon)

Kristina Corso | Communications Specialist | 212.931.6189 | This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries: (For OptraSCAN)

Shruti Soman | Manager – Marketing Communications | 91.20.66540900 x 231 | This email address is being protected from spambots. You need JavaScript enabled to view it.


 
 
 



Your form has been submitted successfully. We have sent brochure of interest on to your email address.




Thanks for interest! We have sent brochure of interest on to your email address.